Ilham Abuljadayel
Co-Founder
TriStem Corp Ltd
UK
Biography
Dr. Ilham Saleh Abuljadayel: discovered the process of retrodifferentiation in the early nineties. This direct reprogramming of differentiated somatic cells is achieved through cell surface receptor contact of more mature adult human cells such as leucocytes. She was awarded worldwide patents on the methodology and device, enabling the production of unprecedented levels of pluripotent stem cells from differentiated cells. Based on her research, Dr. Abuljadayel co-founded the TriStem Group. During the period 1990 to 1995, Dr Abuljadayel worked as a consultant immunologist at the King Fahd Armed Forces Hospital in Jeddah, and from 1996-2000 headed the TriStem Research on retrodifferentiation at the London Hospital, Kings College, Downing College University of Cambridge and Addenbrooke Hospital
Abstract
Abstract : Retrodifferentiation in the Treatment of a Rare Condition: Acquired Aplastic Anaemia
